News: Admedus revenue up 7.09% for FY2014, page-28

First 28 Last

Share
Profile

Follow
pmartinoz

183 Posts.

30/08/14

00:30

Post #: 13898165
Share

Originally posted by ecrawf ↑

Russ its obvious that we have differing opinions but let me clarify/respond.
Of course i place value on other parts of the company but the reason that I made mention of Cardiocell only are:
1/. Other than the 6mill already assigned to the next vaccine trials, its the launching of Cardiocell thats creating the ballooning cash burn.
2/. Its sales of Cardiocell that they are relying on to recover these cost. I see comments like "it will take time", or "have patience give them a chance". The fact is that time is money and if the uptake is slower than forecast (as projected in Morgans lastest report) they will run out. Unfortunately this raises the possiblity of another capital raising being required further diluting value to existing holders which is not good for you or me. Ignore at your own peril.
3/. Most people didn't need points 1 & 2 explained to them.
4/. Unlike others on this forum that regurgitate page after page of the same shite day after day to hype the stock up for there own benefit I chose to tell it as I see it without spending time discussing other divisions of the company that are not going to produce the money needed to cover the burn rate.

And then theres this from you:
"How much will you complain if the results for the Vax is outstanding (if you hold at all)"
"Other than that you have a choice to sell now and we will not have to listen to the complaints"

1/. THIS IS NOT A COMPLAINT. Im purely pointing out information that i believe will keep the sp from hitting Tomboys $1.20 plus sp next year (or anywhere near it). Balance in this forum is badly needed. Whats the point of a forum that only discussed the positives?? How does that help unsophisticated investors when all they read is Tomboys BUY BUY BUY the sp will be $1.20 plus next year. Pigs will fly.
2/. As ive told you twice already I hold plenty of AHZ shares. I hate repeating myself.

Please try and be a little objective Russ, my opinions on the company are not an attack on you and I really don't want to break everything down for you after every post I make.

Expand

Now that is what I like to see on HC. You don't need to agree with others or be contrarian to the extreme but put up your points and discuss the merits.
I agree cash burn is a concern but that doesn't worry me. If they have the goods which will then generate sales then the next 12 months sales figures will show it.
I give the vaccines zero EV too as they will not generate revenue for many years but I am watching results closely as potential there.

AHZ Price at posting: 15.0¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

Shekel Brainweigh and Calmer Co lead innovations in the retail space

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

RCE

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

ARN

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

There are more pages in this discussion • 14 more messages in this thread...

First 28 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $18.00		Change 0.000(0.00%)		Mkt cap ! $341.1M

Open	High	Low	Value	Volume
$18.00	$18.10	$17.75	$72.87K	4.07K

Buyers (Bids)

No.	Vol.	Price($)
1	691	$17.90

Sellers (Offers)

Price($)	Vol.	No.
$18.25	100	1

View Market Depth

No.	Vol.	Price($)
1	691	17.900
1	1	17.800
1	26	17.740
1	443	17.700
1	26	17.650

Price($)	Vol.	No.
18.250	100	1
18.300	150	1
18.490	6	1
18.500	43	1
18.690	550	1

Last trade - 15.40pm 15/07/2024 (20 minute delay)

AVR (ASX) Chart

News: Admedus revenue up 7.09% for FY2014, page-28

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

News: Admedus revenue up 7.09% for FY2014, page-28

Top Stories

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News